News Current page: 20

Migraine is one of the main causes of physical limitations. One in seven persons has experienced a migraine at some point in the past. Chronic migraine affects 5 percent of all migraine patients. With neurostimulation, Dutch-based Salvia BioElectronics B.V. is developing a promising therapeutic approach that offers many sufferers a reason to hope. SHS is […]

Effective October 1, 2020, Tübingen-based medtech investor SHS has appointed Prof. Marc O. Schurr, founder and Executive Board member of Ovesco AG, as Senior Advisor Schurr, a successful medtech entrepreneur and professor of experimental medicine and medical technology, understands what matters when it comes to clinical approvals and regulatory processes In Schurr, SHS gains a […]

Salvia BioElectronics raises EUR 26M (USD 31M) to develop innovative neurostimulation therapy for chronic migraine Series A led by new investors Panakès Partners, INKEF Capital and SHS Gesellschaft für Beteiligungsmanagement Eindhoven, the Netherlands, September 22, 2020 – Salvia BioElectronics B.V., a neurostimulation platform company targeting chronic migraine, today announced it has raised EUR 26M in […]

Our portfolio company Miracor raised 24m EUR to fund three clinical trials, totaling 750 patients, and start commercialization of its PiCSO therapy. The PiCSO therapy reduces infarct sizes and therefore mortality and hospitalization of patients suffering from ST-elevated myocardial infarction (STEMI).

The FAZ published a background article on the active M&A environment in medtech despite (and partially even supported by) the market conditions with a specific focus on the Siemens Healthineers / Varian Medical Systems transaction. Hubertus Leonhardt, managing partner of SHS, has been quoted regarding the current pricing in M&A transactions for healthcare companies.

How has the medical technology industry developed in comparison to the overall economy in recent years? The Schwäbische Zeitung (https://www.schwaebische.de) reports on the SHS Medical Technology Index.

SHS sees medical technology back on track for success in Germany in 2019 Medical technology sector increases turnover by 10% in 2019 In spite of COVID-19, SHS expects the medical technology industry to outperform the German economy as a whole in 2020 as well Effects of the EU Medical Device Regulation (MDR) not yet digested […]

In the spring, we invested in Finnish medical technology company Neuro Event Labs Oy as part of an international consortium. With its product Nelli™, the health tech specialist from Tampere has developed an AI-powered epilepsy diagnostic tool that can be used by patients at home. Epilepsy is one of the most common neurological disorders, affecting […]

Medical technology is a highly dynamic, global growth market. Anyone interested in getting detailed information about this key market should download the Market Study Medical Technology 2020 published by Clairfield International. In addition to renowned organisations such as the German Medical Technology Association (BVMed) and the Working Group Medical Technology of the Mechanical Engineering Industry […]

On June 19, 2020, our Swiss portfolio company Advanced Osteotomy Tools (AOT) successfully completed the last surgery required for the first-in-man clinical study of its proprietary CARLO® system. Given the small delay due to COVID-19, we are now all the more pleased with the outcome. This takes the CARLO® (Cold Ablation Robot-guided Laser Osteotome) system […]

On April 1, 2020, Sascha Alilovic was appointed Managing Partner of SHS. Since he joined SHS in 2018, SHS investors and portfolio companies have appreciated his expertise in the international life science industry and his experience in strategic transactions for national and international medical technology companies. For more information on Sascha Alilovic, click here.

The Red Dot Award is like the Oscar for product design. We would like to congratulate our portfolio company TRI® Dental Implants on its Red Dot Award for the world’s first digital implant matrix®. With this new kind of implant connection, dentists can plan the prosthetics for their patients directly on the implant, without an […]